23836902

Tee MK

2013

Phosphorylation of human cytochrome P450c17 by p38? selectively increases 17,20 lyase activity and androgen biosynthesis.

23840863

Li T

2013

Common variant rs9939609 in gene FTO confers risk to polycystic ovary syndrome.

23841285

Lu L

2013

[Progress of promoting fertility treatment of polycystic ovary syndrome by integrative medicine].

23843684

Romacho T

2013

Visfatin/Nampt: an adipokine with cardiovascular impact.

23843832

Scicchitano P

2012

Cardiovascular Risk in Women With PCOS.

23844380

Dantas WS

2013

Metabolic disturbance in PCOS: clinical and molecular effects on skeletal muscle tissue.

23844634

Hosseinpanah F

2014

Lipid accumulation product and insulin resistance in Iranian PCOS prevalence study.

23845170

de Guevara AL

2013

Evaluation of ovarian function in 35-40-year-old women with polycystic ovary syndrome.

23845740

Mazza A

2014

In PCOS patients the addition of low-dose spironolactone induces a more marked reduction of clinical and biochemical hyperandrogenism than metformin alone.

23846817

Rice S

2013

Metformin inhibits follicle-stimulating hormone (FSH) action in human granulosa cells: relevance to polycystic ovary syndrome.

23846820

Ganie MA

2013

Improved efficacy of low-dose spironolactone and metformin combination than either drug alone in the management of women with polycystic ovary syndrome (PCOS): a six-month, open-label randomized study.

23848208

Shen W

2013

CYP1A1 gene polymorphisms and polycystic ovary syndrome risk: a meta-analysis and meta-regression.

23849090

Ghazeeri G

2013

Anxiety, cognitive, and depressive assessment in adolescents with polycystic ovarian syndrome: a pilot study.

23850029

Faria FR

2013

Polycystic ovary syndrome and intervening factors in adolescents from 15 to 18 years old.

23850301

Ortega-Hrepich C

2013

A freeze-all embryo strategy after in vitro maturation: a novel approach in women with polycystic ovary syndrome?

23852617

Shen W

2014

Common polymorphisms in the CYP1A1 and CYP11A1 genes and polycystic ovary syndrome risk: a meta-analysis and meta-regression.

23855354

El-Mazny A

2013

Anti-M?llerian hormone and antral follicle count for prediction of ovarian stimulation response in polycystic ovary syndrome.

23855355

Erdogan E

2013

Polycystic ovary syndrome is associated with P-wave prolongation and increased P-wave dispersion.

23857221

Greibe E

2013

Metformin lowers serum cobalamin without changing other markers of cobalamin status: a study on women with polycystic ovary syndrome.

23857978

Parker VE

2013

Genetics in endocrinology: genetic forms of severe insulin resistance: what endocrinologists should know.

23860693

da Silva AM

2014

Elevated diastolic blood pressure in insulin-resistant polycystic ovarian syndrome patients.

23861462

Louwers YV

2013

Variants in SULT2A1 affect the DHEA sulphate to DHEA ratio in patients with polycystic ovary syndrome but not the hyperandrogenic phenotype.

23861679

Boqun X

2013

Expression of SET Protein in the Ovaries of Patients with Polycystic Ovary Syndrome.

23864804

Lee H

2013

Adipokines, insulin-like growth factor binding protein-3 levels, and insulin sensitivity in women with polycystic ovary syndrome.

23866168

Linares R

2013

Unilateral or bilateral vagotomy induces ovulation in both ovaries of rats with polycystic ovarian syndrome.

23866924

Li Y

2013

Effect of berberine on insulin resistance in women with polycystic ovary syndrome: study protocol for a randomized multicenter controlled trial.

23869143

Karoli R

2013

Prevalence of hepatic steatosis in women with polycystic ovary syndrome.

23869144

Ayaz A

2013

Metformin-clomiphene citrate vs. clomiphene citrate alone: Polycystic ovarian syndrome.

23869152

Kumar P

2013

Assisted reproduction in polycystic ovarian disease: A multicentric trial in India.

23869585

An Y

2014

The use of berberine for women with polycystic ovary syndrome undergoing IVF treatment.

23869836

Ku?era R

2013

[Determination of anti-M?llerian hormone in women].

23873424

D?bkowska-Hu? A

2013

Anti-M?llerian hormone dynamics during ovulation induction treatment with recombinant follicle-stimulating hormone in women with polycystic ovary syndrome.

23874146

Kubota T

2013

Update in polycystic ovary syndrome: new criteria of diagnosis and treatment in Japan.

23874725

Udhane S

2013

Differential regulation of human 3?-hydroxysteroid dehydrogenase type 2 for steroid hormone biosynthesis by starvation and cyclic AMP stimulation: studies in the human adrenal NCI-H295R cell model.

23875166

Kim JY

2013

Association between serum anti-M?llerian hormone level and ovarian response to mild stimulation in normoovulatory women and anovulatory women with polycystic ovary syndrome.

23875167

Hwang KR

2013

Effects of insulin-sensitizing agents and insulin resistance in women with polycystic ovary syndrome.

23875758

Nilsson E

2013

Gene bionetworks that regulate ovarian primordial follicle assembly.

23875783

Hamed HO

2013

Role of adiponectin and its receptor in prediction of reproductive outcome of metformin treatment in patients with polycystic ovarian syndrome.

23876536

Nybacka ?

2013

Serum antim?llerian hormone in response to dietary management and/or physical exercise in overweight/obese women with polycystic ovary syndrome: secondary analysis of a randomized controlled trial.

23876972

Wang Z

2013

Replication study of RAD54B and GREB1 polymorphisms and risk of PCOS in Han Chinese.

23879009

Milewicz T

2013

[Metformin--new treatment strategies for gynecologic neoplasms].

23880889

Karakurt F

2014

Effect of ethinyl estradiol-cyproterone acetate treatment on asymmetric dimethyl-arginine levels in women with polycystic ovary syndrome.

23884099

Woo YM

2013

microRNA biomarkers in cystic diseases.

23884834

Soydinc E

2013

Increased epicardial fat thickness is related with body mass index in women with polycystic ovary syndrome.

23885694

Panidis D

2013

Age- and body mass index-related differences in the prevalence of metabolic syndrome in women with polycystic ovary syndrome.

23886295

Pimentel AM

2013

Adequacy of ovarian diathermy under ultrasound control: an experimental model.

23886298

Lautatzis ME

2013

Efficacy and safety of metformin during pregnancy in women with gestational diabetes mellitus or polycystic ovary syndrome: a systematic review.

23886450

Bhattacharya SM

2013

Association of vitamin D3 deficiency with clinical and biochemical parameters in Indian women with polycystic ovary syndrome.

23889482

Smolikova K

2013

Effect of 1?,25-dihydroxyvitamin D3 on progesterone secretion by porcine ovarian granulosa cells.

23891270

Bazarganipour F

2013

Predictive factors of health-related quality of life in patients with polycystic ovary syndrome: a structural equation modeling approach.

23895299

Li S

2013

Genetic investigation into ethnic disparity in polycystic ovarian syndrome.

23895379

Shah D

2014

Polycystic ovaries - beyond menopause.

23895991

S?godi L

2013

[Obesity, hormonal and metabolic abnormalities in adolescent girls with polycystic ovary syndrome].

23897006

Brezina PR

2013

Fertility management in the PCOS population: results of a web-based survey at IVF-worldwide.com.

23898913

Sales MF

2013

Correlation between plasminogen activator inhibitor-1 (PAI-1) promoter 4G/5G polymorphism and metabolic/proinflammatory factors in polycystic ovary syndrome.

23899470

Huang QT

2013

Advanced oxidation protein products enhances soluble Fms-like tyrosine kinase 1 expression in trophoblasts: a possible link between oxidative stress and preeclampsia.

23899907

Alphan Z

2013

Increased total Renin levels but not Angiotensin-converting enzyme activity in obese patients with polycystic ovary syndrome.

23900753

Schmidt J

2014

Differential expression of inflammation-related genes in the ovarian stroma and granulosa cells of PCOS women.

23902809

Chen ZJ

2013

[Retrospect and challenge of PCOS research in China].

23902810

Yang DZ

2013

[Development of pediatric and adolescent gynecology in China in current decade].

23904283

Hendriks ML

2013

Influence of ovarian manipulation on reproductive endocrinology in polycystic ovarian syndrome and regularly cycling women.

23904873

Koutlaki N

2013

The relationship between Anti-M?llerian hormone and other reproductive parameters in normal women and in women with polycystic ovary syndrome.

23904883

Ayaz A

2013

Efficacy of combined metformin-clomiphene citrate in comparison with clomiphene citrate alone in infertile women with polycystic ovarian syndrome (PCOS).

23905484

Koleva DI

2013

Adipose tissue hormones and appetite and body weight regulators in insulin resistance.

23905598

Faselis C

2014

The role of renal nerve ablation for the management of resistant hypertension and other disease conditions: benefits and concerns.

23909179

Tomlinson J

2013

Raising awareness of polycystic ovary syndrome.

23909452

Panidis D

2014

The role of orlistat combined with lifestyle changes in the management of overweight and obese patients with polycystic ovary syndrome.

23912750

Wei LN

2013

Inhibitory effects of controlled ovarian stimulation on the expression of GDF9 and BMP15 in oocytes from women with PCOS.

23913733

Van Vugt DA

2013

Effect of insulin sensitivity on corticolimbic responses to food picture in women with polycystic ovary syndrome.

23913942

Rosenfield RL

2013

Clinical review: Adolescent anovulation: maturational mechanisms and implications.

23919188

Chakrabarti J

2013

Serum leptin level in women with polycystic ovary syndrome: correlation with adiposity, insulin, and circulating testosterone.

23920100

Fux Otta C

2013

[Polycystic ovary syndrome: physiopathology review].

23921139

Wenner MM

2013

Androgens influence microvascular dilation in PCOS through ET-A and ET-B receptors.

23926234

Leonhardt H

2014

Ovarian volume and antral follicle count assessed by MRI and transvaginal ultrasonography: a methodological study.

23926485

Farideh ZZ

2010

Effects of chamomile extract on biochemical and clinical parameters in a rat model of polycystic ovary syndrome.

23926521

Talhouk R

2012

Modulation of Cx43 and Gap Junctional Intercellular Communication by Androstenedione in Rat Polycystic Ovary and Granulosa Cells in vitro.

23926533

Zangeneh FZ

2012

Psychological distress in women with polycystic ovary syndrome from imam khomeini hospital, tehran.

23926541

Soria M

2012

Pregnancy predictors after intrauterine insemination: analysis of 3012 cycles in 1201 couples.

23928669

Pelusi C

2013

Parallel variations of insulin-like peptide 3 (INSL3) and antim?llerian hormone (AMH) in women with the polycystic ovary syndrome according to menstrual cycle pattern.

23929197

Rehme MF

2013

[Clinical manifestations, biochemical, ultrasonographic and metabolic of polycystic ovary syndrome in adolescents].

23930405

Jansen T

2013

[Causes and therapy of acne tarda. Acne of mature skin: how to deal with it? (interview by Dr. Elke Oberhofer)].

23930901

Kozica SL

2013

Assessing self-efficacy and self-help methods in women with and without Polycystic Ovary Syndrome.

23933688

Panidis D

2013

The guidelines issued by the European Society for Human Reproduction and Embryology and the American Society for Reproductive Medicine regarding the induction of ovulation with metformin in patients with the polycystic ovary syndrome potentially require reconsideration.

23934697

Wang S

2013

Racial and ethnic differences in physiology and clinical symptoms of polycystic ovary syndrome.

23935130

Ramos RB

2013

Polymorphisms of TCF7L2 gene in South Brazilian women with polycystic ovary syndrome: a cross-sectional study.

23935436

A?maz G

2013

Level of anxiety, depression, self-esteem, social anxiety, and quality of life among the women with polycystic ovary syndrome.

23935612

Mansor F

2013

Labisia pumila Upregulates Peroxisome Proliferator-Activated Receptor Gamma Expression in Rat Adipose Tissues and 3T3-L1 Adipocytes.

23938069

Howland RH

2013

A glucose eater drug as a therapeutic agent in psychiatry.

23939500

Klein DA

2013

Amenorrhea: an approach to diagnosis and management.

23940991

Baldani DP

2013

Clinical, hormonal and metabolic characteristics of polycystic ovary syndrome among obese and nonobese women in the Croatian population.

23940993

Baldani DP

2013

Characteristics of different phenotypes of polycystic ovary syndrome based on the Rotterdam criteria in the Croatian population.

23941020

Kasum M

2013

Spontaneous ovarian hyperstimulation syndrome.

23941060

Lecke SB

2013

Circulating levels and subcutaneous adipose tissue gene expression of pigment epithelium-derived factor in polycystic ovary syndrome and normal women: a case control study.

23942472

Alijotas-Reig J

2013

Current concepts and new trends in the diagnosis and management of recurrent miscarriage.

23945597

Barry JA

2013

Visual-spatial cognition in women with polycystic ovarian syndrome: the role of androgens.

23945839

Mehta J

2013

Phenotypic expression of polycystic ovary syndrome in South Asian women.

23946431

Tan BK

2013

Metformin increases the novel adipokine adipolin/CTRP12: role of the AMPK pathway.

23946629

Ndefo UA

2013

Polycystic ovary syndrome: a review of treatment options with a focus on pharmacological approaches.

23947083

Azurah AG

2013

Diagnostic pitfalls in the evaluation and management of amenorrhea in adolescents.

23947827

Bazarganipour F

2013

Psychological investigation in patients with polycystic ovary syndrome.